Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: William Strop who wrote (1188)	1/10/2000 4:50:00 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 1972

The last few days proves me 75% correct. I've said several times on this thread that one risk with VICL is NOT holding it patiently since, due to all the items in development and the extensive partnering, great news can come out at any time. Correct #1. I Said Friday this could be huge. Correct #2. In late Dec, I thought stock was overbought in the 28s and took 40% off the table, thinking the stock would pull back. Correct #3 until today. Missed 25% gain on the 40% I cashed out. Very wrong #1. Live and learn. Anyway, great news for us longs, whatever amt we current hold. Scott

To: William Strop who wrote (1188)	1/13/2000 3:27:00 PM
From: Brian Malloy	Read Replies (1) \| Respond to of 1972

A little blast from the past at the end for you and the thread, Biotech, B2B, Wireless look to be three key sectors as we head into the new year. Much of the focus is on genomics at this point. Vaccine stocks are on the radar screen and have moved but the mindless masses have not jumped yet. The vaccine stocks are much closer to breaking out with big profits than the genomic concerns at this point. It is one thing to know what a gene does, it is entirely a different process to develop a product that can be sold to consumers. I don?t think people realize that the work has just begun. ?Cures? are not going to start popping out a few month or something like that. Once they realize that vaccines are closer to rolling out FDA approvable products then the money will flow. Message 3186247 Message 2896539 Message 2870230 Regards,